Background. Increasing evidence demonstrate that concentration of protein in infant formula >1.9g/100Kcal with high levels of insulinogenic aminoacids is associated with accelerated weight gain, increased fat mass accumulation and risk of adiposity. Purpose of this study was to conduct a systematic review to determine the metabolic effects in infants feed with infant formula optimized in protein.
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Background
Prevalence of overweight and obesity around the world has increased considerably in the last thirty years. As a consequence, Chronic Disease Related to Nutrition (CRN) is one of the most prevalent conditions, which represents a major challenge for public health given the broad spectrum of associated pathologies (Diabetes, Hypertension, others), which are intimately related to the 70% cases of dead in young adults. Recent evidence has shown the effects of prenatal programming as a predictor of obesity and NRWD in adulthood. It is known that early and excessive weight gain during the first two years of life are associated with a significant increase in the risk of obesity in later stages. (5-7) Some of these studies showed a lower risk of obesity in breastfeeding babies, which seems to be related to the amount and type of protein intake (8, 9) We know breast milk is the ideal food in the first months of life and it has been well documented that the composition of this milk changes considerably in the course of the first year after delivery, mainly in protein composition and concentration. The amount of protein is on average 2.2 to 2.5g/100 kcal during the first days of lactation and decreases to 1.2-1.8g/100 kcal at six months of age. than the previous trials (1.5g/100Kcal), showed a lower body mass index at 2 years of follow-up than that observed in infants fed with concentrations high protein levels (2.2g/100Kcal). (19) Considering this evidence, the objective of the present review was to evaluate, through the methodology of the systematic review, the existing publications to demonstrate the effect of optimized protein (1.5 to 1.9g / 100Kcal and modified aminoacids profile) compared to the use of high protein (> 1.9g / 100Kcal) in infant formulas on the metabolic and nutritional health of infants.
Methods
This study was conducted and reported according to the general guidelines recommended by the Primary Reporting Items for Systematic Reviews and Metaanalyses (PRISMA) Statement. (Table 1 ) (20) Study eligibility criteria
The a priori inclusion criteria for this meta-analysis were as follows: (1) (4) primary outcomes and (5) secondary outcomes. The primary outcomes for this study was BMI z-score and fat mass accumulation. Secondary outcomes included weight gain, weight for age Z score, length for age Z score, weight for length Z score, BUN (mmol/dL) and IgFb1 (ng/ml) in serum. Missing primary outcome data were requested from the author(s). Publication bias was avoided by including data from all published study. Data abstraction was performed using the same procedure as the selection of studies.
Risk of bias
The Cochrane Collaboration risk of bias instrument was used to assess bias across six categories: (1) random sequence generation, (2) allocation concealment, (3) blinding of participants and personnel, (4) blinding of outcome assessment, (5) incomplete outcome data, and (6) 
Statistical analysis
Effect size (ES) changes in BMI z-score and fat mass were calculated by subtracting the difference in the optimized protein group from the difference in the control group and reported as standardized mean differences (SMD). Variances were calculated from the pooled standard deviations in the intervention and control groups. If standard deviations were not available, these were calculated from reported 95% confidence intervals (CI) or standard deviation (SD). All secondary outcomes were calculated using the same approach as for BMI primary outcomes.
Random models that incorporate heterogeneity into the overall estimate were used to pool results for primary and secondary outcomes from each study. (25) Nonoverlapping 95% CI were considered statistically significant. Heterogeneity of results between studies was examined using I 2 . (26) Small-study effects (publication bias, etc.) were examined using the regression approach of Egger et al. (27, 28) Results 27 studies were evaluated. (Fig 1) (14-19, 29-37 ) After evaluation of bias, only 15 studies were included in meta-analysis. (Table 1 
Discussion and recommendation
It is well established that obesity is a major public health burden in most developed countries, with a foretelling of risk in developing countries worldwide. Mexico is one of the countries with one of the most higher prevalence of obesity in children. (38) Recent evidence shows that in some extent obesity start on the first year of life.
(39) Accumulating scientific evidence suggests that excessive protein intake during infancy may increase the subsequent risk of obesity. More than 10 years ago, Koletzko group showed in a large cross-sectional study including more than 9,000 children in Germany that breastfed children have a markedly reduced later risk of obesity at school age than previously bottle (formula)-fed children, with an inverse dose response relationship between breastfeeding duration and the adjusted odds (36, 37) which extends the range of clinically and biological effects of optimized protein from 1.8 to 1.6-1.9g / 100Kcal in infants. While we wait for new evidence to be published, we are able to conclude that feed the infant with 1.6 to 1.9g/100Kcal of protein in infant formulas could be significantly associated with a lower body mass index and lower fat mass gain.
